Tech Company Financing Transactions

Immune-Onc Therapeutics Funding Round

Immune-Onc Therapeutics closed a $73 million Series B funding round on 4/1/2021. Investors included Ocean Pine Healthcare Fund, Northern Light Venture Capital and Octagon Investments Fund.

Transaction Overview

Announced On
4/1/2021
Transaction Type
Venture Equity
Amount
$73,000,000
Round
Series B
Proceeds Purpose
Proceeds from the financing will allow Immune-Onc to advance its portfolio of blood cancer and solid tumor immunotherapies targeting myeloid checkpoints with a focus on the LILRB family.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
795 San Antonio Rd.
Palo Alto, CA 94303
USA
Phone
Undisclosed
Email Address
Overview
Immune-Onc Therapeutics, Inc. is a newly established biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment.
Profile
Immune-Onc Therapeutics LinkedIn Company Profile
Social Media
Immune-Onc Therapeutics Company Twitter Account
Company News
Immune-Onc Therapeutics News
Facebook
Immune-Onc Therapeutics on Facebook
YouTube
Immune-Onc Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Charlene Liao
  Charlene Liao LinkedIn Profile  Charlene Liao Twitter Account  Charlene Liao News  Charlene Liao on Facebook
Chief Medical Officer
Paul Woodard
  Paul Woodard LinkedIn Profile  Paul Woodard Twitter Account  Paul Woodard News  Paul Woodard on Facebook
Founder
Guo-Liang Yu
  Guo-Liang Yu LinkedIn Profile  Guo-Liang Yu Twitter Account  Guo-Liang Yu News  Guo-Liang Yu on Facebook
VP - Bus. Development
Ji Li
  Ji Li LinkedIn Profile  Ji Li Twitter Account  Ji Li News  Ji Li on Facebook
VP - Bus. Development
An Song
  An Song LinkedIn Profile  An Song Twitter Account  An Song News  An Song on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/1/2021: Uniphore venture capital transaction
Next: 4/1/2021: Pipe venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary